| PRODUCT DESCRIPTION |
| 10916 AZITHRONYCIN FOR INJECTION[500MG/VIAL] EACH VIAL CONTAINS AZITHROMYCIN MONOHYDRATE USP EQUIVALENT TO AZITHROMYCIN |
| 10916 AZITHRONYCIN FOR INJECTION[500MG/VIAL] EACH VIAL CONTAINS AZITHROMYCIN MONOHYDRATE USP EQUIVALENT TO AZITHROMYCIN |
| ALITHRO-250 TABLET(1X6) AZITHROMYCIN 250 MG, B/NO-ALTAT-1602, M.DT.09/16, E.D.08/19 |
| ALITHRO-500 TABLET(10X1X3) AZITHROMYCIN 500 MG, B/NO-ALTAM-1601.ALTAM-1602, M.DT.07/16, E.D.06/19 & 08/16,07/19 |
| AZEE TABLETS (20 PACKX1=20 TABS)EACH TABS CONT: AZITHROMYCIN 1000MG |
| AZEE TABLETS (20 PACKX1=20 TABS)EACH TABS CONT: AZITHROMYCIN 1000MG |
| AZEE TABLETS (20 PACKX1=20 TABS)EACH TABS CONT: AZITHROMYCIN 1000MG |
| AZIFAST 250MG TABLETS (AZITHROMYCIN DIHYDRATE) (10 X 1 X 6 S PER PACK) |
| AZIFAST 250MG TABLETS (AZITHROMYCIN DIHYDRATE) (105 X 10 X 1 X 6 S PER LOT OF N.C.V) |
| AZIHELP SUSPENSION, EACH 5ML CONT.AZITHROMYCIN DIHYDRATE EQ.TO AZITHROMYCIN USP 200MG BN.CS1672 DM.11/16 ED.10/19 (15ML) |
| AZIHELP-250,EACH TAB.CONT.AZITHROMYCIN DIHYDRATE EQ.TO AZITHROMYCIN USP 250MG,BN.CT16120 DM.10/16 ED.09/19 (1X6) |
| AZIHELP-500,EACH TAB.CONT.AZITHROMYCIN DIHYDRATE EQ.TO AZITHROMYCIN USP 500MG,BN.TE16125,TE16126 DM.10/16 ED.09/19 (1X3) |
| AZILEB - 500 TABLET USP 3 S X X 10 (AZITHROMYCIN 500 MG.) W. PROM. MAT DIARY & PAD QTY 500 + 300 PHARMACEUTICAL PRODUCT |
| AZIMAX 500 (AZITHROMYCIN DIHYDRATE TABLETS 500MG) (1X3 S) |
| AZISAN-250 TABLETS (CONTAINING AZITHROMYCIN TABLETS USP 250MG IN PACKING 5 STRIPS OF X 6 TABLETS PER BOX) |
| AZITHROMYCIN 250 (1X6), BATCH NO: E1609008 MFG DATE:- SEP 16, EXP DATE:-AUG-19 |
| AZITHROMYCIN 500 (1X3), BATCH NO: E1609009 MFG DATE:SEP-16, EXP DATE:- AUG-19 |
| AZITHROMYCIN DIHYDRATE |
| AZITHROMYCIN DIHYDRATE {AZITHROMYCIN USP(DIHYDRATE)} (OTHERS) - BULK DRUG |
| AZITHROMYCIN DIHYDRATE PH. EUR (ERYTHROMYCIN AND ITS DERIVATIVES; SALTS THEREOF- MEIS SR.NO-1185) |
| AZITHROMYCIN FOR ORAL SUSPENSION 200MG |
| AZITHROMYCIN FOR ORAL SUSPENSION 200MG |
| AZITHROMYCIN IMPURITY F |
| AZITHROMYCIN STEP 4(DRUG INTERMEDIATE)-(ERYTHROMYCIN AND ITS DERIVATIVES SALTS THEREOF-1185) |
| AZITHROMYCIN TABLETS 250MGBATCH NO:T-5085,MFG: 10/2016,EXP:09/2019 |
| AZITHROMYCIN TABLETS 500MGBATCH NO:T-5086,MFG: 10/2016,EXP:09/2019 |
| AZITHROMYCIN TABLETS USP 500MG (33333 X1 X 3) - BOX |
| AZITHROMYCIN TABLETS USP 500MG(QTY OF AZITHROMYCIN 0.5406GM PER TABS & TOTAL QTYCONSUMED 596.8224 KGS) |
| AZITHROMYCIN TABLETS USP 500MG. MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIX |
| DRUGS & PHARMA,MEDICINES AZICURE 200MG (AZITHROMYCIN 200MG SUSPENSION) |
| DRUGS & PHARMA,MEDICINES AZICURE 200MG (AZITHROMYCIN 200MG SUSPENSION) |
| FREE SAMPLE OF NCV(RS.5000/-):ZAHA 250 MG TABLETS[90 PACK X 10 X 1 X 6 = 5400 TABS][AZITHROMYCIN TABS 250MG]AS PER INV |
| HARMLESS MEDICINE : AZEE 500 (AZITHROMYCIN DIHYDRATE TABLETS 500MG) 1 X 3 S TABS |
| MEDICAMENTS PHARMA:-AZITAR-250 TAB(10X1X6) AZITHROMYCIN DIHYDRATE U.S.P. 250 MGB. NO. MTZ9-1603, M.D.11/16, E.D.10/19 |
| MEDICAMENTS PHARMA:-AZITAR-500 TAB(10X1X3) AZITHROMYCIN DIHYDRATE U.S.P. 250 MGB. NO. MTZ5-1607, M.D.11/16, E.D.10/19 |
| PHARMACEUTICAL RAW MATERIAL-AZITHROMYCINDIHYDRATE USP 36 (BITTERLESS |
| SAMPLES OF NO COMMERCIAL VALUE, VALUE FOR CUSTOMS PURPOSE ONLY ZITHROX 200(AZITHROMYCIN ORAL SUSPENSION 200MG / 5ML) 1X1 |
| ZAHA 250 MG TABLETS[907 PACKX 10 X 1 X 6= 54420 TABS] [AZITHROMYCIN TABLETS 250MG][EACH TABLET CONTAINS :AS PER INV |
| ZAHA TABLETS 500MG[300 PACK X 10 X 1 X 3= 9000 TABS][EACH FILM COATED TABS CONT: AZITHROMYCIN DIHYDRATE 500MG] |
| ZIOMYCIN-250 TABLETS 1X6 S (AZITHROMYCIN250MG TABLETS),B.NO.ZC6005,D.O.M.08/2016,D.O.E. 07/2019 |
| ZIOMYCIN-250 TABLETS 1X6 S(AZITHROMYCIN 250MG TABLETS) BAT.NO.ZC6005 DOM: 08/2016 DOE: 07/2019 |
| ZIOMYCIN-500 TABLETS 1X3 S(AZITHROMYCIN 500MG TABLETS) BAT.NO.ZD6005 DOM: 08/2016 DOE: 07/2019 |
| ZITHROX 200(AZITHROMYCIN ORAL SUSPENSION200MG / 5ML) 1X15 ML |